Clinical Trial Update: WiCS-LV Post Market Surveillance Registry

View source ↗

Summary

Post-market surveillance registry for the WiCS-LV wireless left ventricular cardiac resynchronization therapy system; the study is active but not recruiting and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: EBR Systems, Inc. | Conditions: Cardiac Resynchronization Therapy | Status: ACTIVE_NOT_RECRUITING